Decoupling T cell cytotoxicity: a CCL21+ICAM1-based synthetic immune niche enhances tumor elimination by accelerating lytic hit delivery
Manish Kumar Gupta, Rawan Zoabi, Sofi Yado, Jörn Starruß, Benjamin Geiger, Haralampos Hatzikirou · 2026
Read Decoupling T cell cytotoxicity: a CCL21+ICAM1-based synthetic immune niche enhances tumor elimination by accelerating lytic hit delivery by Manish Kumar Gupta, Rawan Zoabi, Sofi Yado, Jörn Starruß, Benjamin Geiger, Haralampos Hatzikirou (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13670589.txt.
Description
Manish Kumar Gupta and co-authors split the T cell killing act into steps to learn which step a lab-grown niche boosts. The niche, a synthetic bed of two fixed signals, CCL21 and ICAM1, grows killer T cells for cancer care while they keep their bite. Past work showed the gain but not its source. Their 2026 study films killer cells hunting a melanoma line, then fits a math model to the film.
Death of a target took about four hits, not one. Niche-raised cells did not find targets in a way that could be fairly weighed. What rose, firm and clear, was the pace at which hits land once a cell locks on. A wide sensitivity test showed hit pace beats find pace for curbing tumors. Growth beds should feed the hit step first, they urge.
Catalog record
| CREATOR | Manish Kumar Gupta, Rawan Zoabi, Sofi Yado, Jörn Starruß, Benjamin Geiger, Haralampos Hatzikirou |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 47 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |